2-203867946-G-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_005214.5(CTLA4):c.4G>T(p.Ala2Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005214.5 missense
Scores
Clinical Significance
Conservation
Publications
- autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiencyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005214.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTLA4 | NM_005214.5 | MANE Select | c.4G>T | p.Ala2Ser | missense | Exon 1 of 4 | NP_005205.2 | ||
| CTLA4 | NM_001037631.3 | c.4G>T | p.Ala2Ser | missense | Exon 1 of 3 | NP_001032720.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTLA4 | ENST00000648405.2 | MANE Select | c.4G>T | p.Ala2Ser | missense | Exon 1 of 4 | ENSP00000497102.1 | ||
| CTLA4 | ENST00000487393.1 | TSL:1 | c.4G>T | p.Ala2Ser | missense | Exon 1 of 2 | ENSP00000497319.1 | ||
| CTLA4 | ENST00000696479.1 | c.76G>T | p.Ala26Ser | missense | Exon 2 of 5 | ENSP00000512655.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251344 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461464Hom.: 0 Cov.: 29 AF XY: 0.00000963 AC XY: 7AN XY: 727070 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2 of the CTLA4 protein (p.Ala2Ser). This variant is present in population databases (rs767352102, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CTLA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 542072). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at